Anzeige
Mehr »
Login
Freitag, 18.10.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
5 Millionen Unzen und steigend: NexGold Mining's unerschlossene Goldstraße
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D48V | ISIN: CA65344X1050 | Ticker-Symbol: O83
Lang & Schwarz
18.10.24
07:22 Uhr
0,044 Euro
-0,044
-100,00 %
1-Jahres-Chart
NEXTGEN FOOD ROBOTICS CORP Chart 1 Jahr
5-Tage-Chart
NEXTGEN FOOD ROBOTICS CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,0370,05107:22
0,0000,00007.10.
GlobeNewswire (Europe)
178 Leser
Artikel bewerten:
(1)

NextGen Food Robotics Corp. Provides Bi-Weekly MCTO Status Update

VANCOUVER, BC, Oct. 08, 2024 (GLOBE NEWSWIRE) -- NextGen Food Robotics Corp. (the "Company") (CBOE: NGRB; OTC Pink: NGRBF; Frankfurt: O83) is providing an update in accordance with National Policy 12-203 - Management Cease Trade Orders ("NP 12-203").

On August 13, 2024, the Company announced that it applied for a management cease trade order ("MCTO") with the British Columbia Securities Commission ("BCSC") in connection with the delay in filing of its audited annual financial statements for the year ended April 30, 2024, related management discussion and analysis, CEO and CFO certificates and annual information form for the fiscal year ended April 30, 2024 (collectively, the "Required Documents") by the prescribed filing deadline (the "Original Announcement"). At that time, based on information then-available, the Company expected to file the Required Documents by August 31, 2024. The MCTO was issued on July 30, 2024 and restricts its Chief Executive Officer and Chief Financial Officer from trading in securities of the Company, whether direct or indirect, until the Company files the Required Documents and the BCSC revokes the MCTO. On August 27, 2024, in its first bi-weekly status update, the Company announced that it expected to file the Required Documents by September 16, 2024. On September 12, 2024, the Company announced that it expected to file the Required Documents by September 27, 2024. On September 24, 2024, the Company announced that it expected to file the Required Documents by October 11, 2024.

As of today's date, the Company expects that the Required Documents will be filed by November 1, 2024. In addition, as previously announced on September 27, 2024, the Company's interim financial report, related management discussion and analysis and certificates of the Chief Executive Officer and Chief Financial Officer for the first quarter of 2024 ended July 31, 2024 (the "Q1 Interim Report") which was required to be filed by September 16, 2024, is now expected to be filed by November 1, 2024. The Company will file the Q1 Interim Report in conjunction with, and immediately following, the filing of the Required Documents.

The Company confirms that since the date of the Original Announcement: (i) other than as described above and in its first, second and third bi-weekly status update, there have been no changes to the information set out in the Original Announcement that would be expected to be material to an investor; (ii) there has been no failure by the Company in fulfilling its stated intentions with respect to satisfying the provisions of the alternative information guidelines set out in NP 12-203; (iii) other than the failure to file the Q1 Interim Report, there has not been any other specified default by the Company under NP 12-203, and, no such other default is anticipated; and (iv) there is no other material information concerning the affairs of the Company that has not been generally disclosed.

The Company confirms it will continue to satisfy the provisions of the alternative information guidelines set out in NP 12-203 so long as it remains in default of the requirement to file the Required Documents and the Q1 Interim Report.

About NextGen Food Robotics
?Nextgen Food Robotics operates commissary and ghost kitchens from its two locations in Vancouver, BC. Additionally, the Company is developing the "Lily app", which is an AI-powered mobile application designed to provide personalized food recommendations and automated meal-planning.

ON BEHALF OF THE BOARD OF DIRECTORS
Paul Francisco Rivas, Chief Executive Officer
1 (236) 471-1357
privas@nextgenai.ca

Cautionary Note on Forward-Looking Information

This news release contains certain forward-looking statements within the meaning of applicable securities laws with respect to the Company. These forward-looking statements generally are identified by words such as "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," and similar expressions and in this news release include statements respecting the timing of filing of the Company's Required Filings and Q1 Interim Report, and Company's compliance with the MCTO and NP 12-203. In particular, this news release contains forward-looking information relating to the anticipated date for filing the annual financial statements for the year ended April 30, 2024, related management's discussion and analysis, related certifications for the financial year ended April 30, 2024, the Company's annual information form for the fiscal year ended April 30, 2024 and the Q1 Interim Report. Although the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Company can give no assurance that they will prove to be correct. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this news release. The forward-looking statements included in this news release are expressly qualified by this cautionary statement. The forward-looking statements and information contained in this news release are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable laws.

Neither the Cboe Canada nor its Market Regulator (as that term is defined in the Listing Manual of Cboe Canada) accepts responsibility for the adequacy or accuracy of this news release.


© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.